Stockscreener 앱 받기
69.73
0.23%
0.16
시간 외 거래:
69.69
-0.04
-0.06%
Corcept Therapeutics Inc 주식(CORT)의 최신 뉴스
Price momentum metrics for Corcept Therapeutics Incorporated explainedQuarterly Profit Review & Daily Price Action Insights - Newser
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension - TipRanks
Can Corcept Therapeutics Incorporated rally from current levelsMarket Movement Recap & Community Supported Trade Ideas - Newser
Regression analysis insights on Corcept Therapeutics Incorporated performanceNew Guidance & Verified Momentum Watchlists - Newser
Earnings visualization tools for Corcept Therapeutics Incorporated2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser
Can momentum traders help lift Corcept Therapeutics IncorporatedEarnings Trend Report & Capital Efficient Trade Techniques - Newser
Analyzing drawdowns of Corcept Therapeutics Incorporated with statistical toolsWeekly Market Summary & Weekly High Potential Stock Alerts - Newser
Corcept Therapeutics Incorporated’s volatility index tracking explainedQuarterly Profit Review & Consistent Income Trade Ideas - Newser
Using economic indicators to assess Corcept Therapeutics Incorporated potentialJuly 2025 News Drivers & Entry and Exit Point Strategies - Newser
Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock? - MSN
Top chart patterns to watch in Corcept Therapeutics IncorporatedTrade Risk Report & Smart Swing Trading Techniques - Newser
Insider Transactions Reported | Corcept Therapeutics(CORT)saw insider trading activity on 8/26/2025 - AInvest
Corcept Therapeutics CORT CBO Robb Charles Buys, Sells 5000 Shares on Aug 22 - AInvest
Using RSI to spot recovery in Corcept Therapeutics IncorporatedWeekly Trend Report & Low Drawdown Momentum Ideas - Newser
Is Corcept Therapeutics Incorporated meeting your algorithmic filter criteriaPortfolio Risk Summary & High Win Rate Trade Tips - Newser
How to track smart money flows in Corcept Therapeutics IncorporatedWeekly Trade Summary & Community Consensus Trade Signals - Newser
JMEE Analysts Predict 11% Upside for Holdings - AInvest
Published on: 2025-08-25 05:47:25 - Newser
What Technical Tools Say About Corcept Therapeutics Incorporated Recovery2025 Breakouts & Breakdowns & Real-Time Volume Triggers - Newser
Has Corcept Therapeutics Incorporated found a price floorJobs Report & Free Technical Pattern Based Buy Signals - Newser
Can you recover from losses in Corcept Therapeutics IncorporatedJuly 2025 Update & Breakout Confirmation Trade Signals - Newser
Canaccord Genuity Maintains a Buy on Corcept Therapeutics (CORT), Retains a $137 PT - Yahoo Finance
Real time pattern detection on Corcept Therapeutics Incorporated stock2025 Macro Impact & Free Daily Entry Point Trade Alerts - Newser
When is the best time to exit Corcept Therapeutics IncorporatedTrade Entry Report & Fast Moving Trade Plans - Newser
Is Corcept Therapeutics Incorporated a good ESG investmentJuly 2025 Intraday Action & High Return Trade Guides - classian.co.kr
With 70% Institutional Ownership, Corcept Therapeutics Incorporated (NASDAQ:CORT) Is a Favorite Amongst the Big Guns - 富途牛牛
Using data tools to time your Corcept Therapeutics Incorporated exit2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Competitive Positioning of Corcept Therapeutics Incorporated: Is It Leading or LaggingWeekly Volume Report & Technical Pattern Recognition Alerts - Newser
Corcept Therapeutics Advances Liver Fat Reduction Study with Miricorilant - MSN
Corcept Therapeutics: Buy Rating Backed by Promising Developments in Glucocorticoid Modulation and Oncology Expansion - TipRanks
Watch for Bullish Crossover in Corcept Therapeutics IncorporatedJuly 2025 Closing Moves & Consistent Profit Focused Trading Strategies - beatles.ru
CORT Q2 Deep Dive: Product Supply Constraints and Pipeline Progress Reshape Outlook - Yahoo Finance
5 Must-Read Analyst Questions From Corcept’s Q2 Earnings Call - Yahoo Finance
Corcept Therapeutics Insider Sold Shares Worth $2,512,452, According to a Recent SEC Filing - MarketScreener
Corcept therapeutics director Swisher sells $159k in shares By Investing.com - Investing.com Nigeria
Corcept therapeutics officer sells $2.5M in shares By Investing.com - Investing.com Australia
Corcept therapeutics director Swisher sells $159k in shares - Investing.com
Corcept therapeutics officer sells $2.5M in shares - Investing.com
Corcept Therapeutics Announces CDO William Guyer's Share Buy and Sell Transactions - AInvest
Corcept Therapeutics: Pioneering a $2.8B Market in Type 2 Diabetes via Hypercortisolism Treatment - AInvest
Corcept's Q2 Demand Grows 60% Penetrating Large Type 2 Diabetes Market Early (NASDAQ:CORT) - Seeking Alpha
Corcept Therapeutics’ MOMENTUM Study: Assessing Hypercortisolism in Resistant Hypertension - TipRanks
Corcept Therapeutics Advances in Ovarian Cancer Treatment with New Phase 2 Study - TipRanks
Why Corcept Therapeutics' (NASDAQ:CORT) Earnings Are Better Than They Seem - Yahoo Finance
Assessing the Impact of Pre-Scheduled Insider Sales at Corcept Therapeutics on Investor Confidence and Market Dynamics - AInvest
Corcept Therapeutics Insider Sold Shares Worth $2,373,237, According to a Recent SEC Filing - MarketScreener
Corcept Therapeutics Insider Sold Shares Worth $393,128, According to a Recent SEC Filing - MarketScreener
Corcept therapeutics officer Lyon sells $393k in shares By Investing.com - Investing.com Nigeria
0.98%
8.06%
자본화:
|
볼륨(24시간):